Abstract
3-O-(3′,3′-dimethylsuccinyl) betulinic acid, also termed PA-457 or DSB, is a novel HIV-1 inhibitor that blocks virus maturation by disrupting cleavage of the capsid precursor, CA-SP1. To better define the molecular target for PA-457, we prepared a panel of mutant viruses with point deletions spanning the CA-SP1 cleavage domain and characterized each of these viruses for PA-457 sensitivity. Our results indicate that amino acid residues in the N-terminal half of SP1 serve as determinants of PA-457 activity, while residues in the C-terminal half of SP1 were not involved in compound activity. These findings support and extend previous observations that PA-457 is a specific inhibitor of CA-SP1 cleavage and identify the CA-SP1 domain as the primary viral determinant for this novel inhibitor of HIV-1 replication.
Original language | English |
---|---|
Pages (from-to) | 217-224 |
Number of pages | 8 |
Journal | Virology |
Volume | 356 |
Issue number | 1-2 |
DOIs | |
State | Published - Dec 5 2006 |
Bibliographical note
Funding Information:This work was supported, in part, by Public Health Service Grant 5 R44 AI051047-03 to G.P.A. from the National Institutes of Health, National Institute for Allergy and Infectious Disease.
Keywords
- CA-SP1 cleavage
- HIV
- Maturation inhibitor
- PA-457
- Viral determinants
ASJC Scopus subject areas
- Virology